These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29709290)

  • 1. The use of routinely collected patient-reported outcome measures in rheumatoid arthritis.
    Hiligsmann M; Rademacher S; Kaal KJ; Bansback N; Harrison M
    Semin Arthritis Rheum; 2018 Dec; 48(3):357-366. PubMed ID: 29709290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
    Stevenson M; Archer R; Tosh J; Simpson E; Everson-Hock E; Stevens J; Hernandez-Alava M; Paisley S; Dickinson K; Scott D; Young A; Wailoo A
    Health Technol Assess; 2016 Apr; 20(35):1-610. PubMed ID: 27140438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes Reported in Prospective Long-Term Observational Studies and Registries of Patients With Rheumatoid Arthritis Worldwide: An Outcome Measures in Rheumatology Systematic Review.
    Lopez-Olivo MA; Zogala RJ; des Bordes J; Zamora NV; Christensen R; Rai D; Goel N; Carmona L; Pratt G; Strand V; Suarez-Almazor ME
    Arthritis Care Res (Hoboken); 2021 May; 73(5):649-657. PubMed ID: 32004421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.
    Keystone EC; Taylor PC; Tanaka Y; Gaich C; DeLozier AM; Dudek A; Zamora JV; Cobos JAC; Rooney T; Bono S; Arora V; Linetzky B; Weinblatt ME
    Ann Rheum Dis; 2017 Nov; 76(11):1853-1861. PubMed ID: 28798049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treat-to-target in rheumatoid arthritis: Evaluating the patient perspective using the Patient Opinion Real-Time Anonymous Liaison system: The RA T2T PORTAL study.
    Benham H; Rutherford M; Kirby S; Stebbings S; White D; Sim D; Harrison A
    Int J Rheum Dis; 2019 May; 22(5):874-879. PubMed ID: 30793870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain in quality-adjusted life-years in patients with rheumatoid arthritis during 1 year of biological therapy: a prospective study in clinical practice.
    Linde L; Sørensen J; Østergaard M; Hetland ML
    J Rheumatol; 2013 Sep; 40(9):1479-86. PubMed ID: 23818719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Early Rheumatoid Arthritis Treatment Evaluation Registry (ERATER) in the United States.
    Sokka T; Pincus T
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S178-81. PubMed ID: 16273804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of patients who rate symptoms of rheumatoid arthritis as 'satisfactory'.
    Gwinnutt JM; Hyrich KL; Lunt M; ; Barton A; Verstappen SMM
    Rheumatology (Oxford); 2020 Aug; 59(8):1853-1861. PubMed ID: 31729526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Reporting of Patient-reported Outcomes in Studies of Patients with Rheumatoid Arthritis: A Systematic Review of 250 Articles.
    Kilic L; Erden A; Bingham CO; Gossec L; Kalyoncu U
    J Rheumatol; 2016 Jul; 43(7):1300-5. PubMed ID: 27084908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry.
    Harrold LR; John A; Best J; Zlotnick S; Karki C; Li Y; Greenberg JD; Kremer JM
    Clin Rheumatol; 2017 Sep; 36(9):2135-2140. PubMed ID: 28718043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A paradigm shift in studies based on rheumatoid arthritis clinical registries.
    Cho SK; Sung YK
    Korean J Intern Med; 2019 Sep; 34(5):974-981. PubMed ID: 30759964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tofacitinib in Combination With Conventional Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient-Reported Outcomes From a Phase III Randomized Controlled Trial.
    Strand V; Kremer JM; Gruben D; Krishnaswami S; Zwillich SH; Wallenstein GV
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):592-598. PubMed ID: 27565000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment.
    Schiff M; Takeuchi T; Fleischmann R; Gaich CL; DeLozier AM; Schlichting D; Kuo WL; Won JE; Carmack T; Rooney T; Durez P; Shaikh S; Hidalgo RP; van Vollenhoven R; Zerbini CAF
    Arthritis Res Ther; 2017 Sep; 19(1):208. PubMed ID: 28923098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to routinely collect data on patient-reported outcome and experience measures in renal registries in Europe: an expert consensus meeting.
    Breckenridge K; Bekker HL; Gibbons E; van der Veer SN; Abbott D; Briançon S; Cullen R; Garneata L; Jager KJ; Lønning K; Metcalfe W; Morton RL; Murtagh FE; Prutz K; Robertson S; Rychlik I; Schon S; Sharp L; Speyer E; Tentori F; Caskey FJ
    Nephrol Dial Transplant; 2015 Oct; 30(10):1605-14. PubMed ID: 25982327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with the first TNF inhibitor in rheumatoid arthritis patients in the Hellenic Registry of Biologic Therapies improves quality of life especially in young patients with better baseline functional status.
    Boubouchairopoulou N; Flouri I; Drosos AA; Boki K; Settas L; Zisopoulos D; Skopouli FN; Papadopoulos I; Iliopoulos A; Kyriopoulos J; Boumpas DT; Athanasakis K; Sidiropoulos P
    Clin Exp Rheumatol; 2016; 34(6):999-1005. PubMed ID: 27749220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease.
    Michaud K; Berglind N; Franzén S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Nyberg F; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SM; Wesby-van Swaay E; Yamanaka H; Askling J
    Ann Rheum Dis; 2016 Oct; 75(10):1797-805. PubMed ID: 26857699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use and detailed metric properties of patient-reported outcome measures for rheumatoid arthritis: a systematic review covering two decades.
    Küçükdeveci AA; Elhan AH; Erdoğan BD; Kutlay Ş; Gökmen D; Ateş C; Yüksel S; Lundgren-Nilsson A; Escorpizo R; Stucki G; Tennant A; Conaghan PG
    RMD Open; 2021 Aug; 7(2):. PubMed ID: 34376556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry.
    Buitinga L; Braakman-Jansen LM; Taal E; Kievit W; Visser H; van Riel PL; van de Laar MA
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):826-32. PubMed ID: 22262513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of patient-reported outcome measures and patient-reported experience measures in renal units in Australia and New Zealand: A cross-sectional survey study.
    Morton RL; Lioufas N; Dansie K; Palmer SC; Jose MD; Raj R; Salmon A; Sypek M; Tong A; Ludlow M; Boudville N; McDonald S
    Nephrology (Carlton); 2020 Jan; 25(1):14-21. PubMed ID: 30838732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis.
    Sung YK; Cho SK; Kim D; Choi CB; Won S; Bang SY; Cha HS; Choe JY; Chung WT; Hong SJ; Jun JB; Kim HA; Kim J; Kim SK; Kim TH; Lee HS; Lee J; Lee J; Lee SS; Lee SW; Lee YA; Nah SS; Suh CH; Yoo DH; Yoon BY; Bae SC;
    Rheumatol Int; 2017 Jun; 37(6):975-982. PubMed ID: 28132102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.